Back to search results

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Pancreatic Cancer · Pancreatic Cancer Metastatic · PDAC · PDAC - Pancreatic Ductal Adenocarcinoma · Pancreatic Ductal Adenocarcinoma · Pancreatic Adenocarcinoma Metastatic · Pancreatic Ductal Adenocarcinoma (PDAC) · Pancreatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope, Phoenix, Arizona, United States

    Contact: Study coordinator (Study Team) · phxresearch@coh.org

  • City of Hope, Duarte, California, United States

    Contact: Study coordinator (Jalene Tangen) · jtangen@coh.org

  • Medical Oncology Hematology Consultants, Newark, Delaware, United States

    Contact: Study coordinator (Elizabeth MacWade) · elizabeth.macwade@usoncology.com

  • Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida, United States

    Contact: Study coordinator (Christine Gerdes) · cgerdes@hemoncfl.com

  • Piedmont Healthcare, Atlanta, Georgia, United States

    Contact: Study coordinator (Eyal Meiri, MD)

  • Illinois Cancer Specialists, Arlington Heights, Illinois, United States

    Contact: Study coordinator (Study Team) · aearles@illinoiscancercare.com

  • City of Hope, Chicago, Illinois, United States

    Contact: Study coordinator (Jalene Tangen) · jtangen@coh.org

  • OSF Medical Center, Peoria, Illinois, United States

    Contact: Study coordinator (Peyton Swearingen) · peyton.o.swearingen@osfhealthcare.org

  • Maryland Oncology, Columbia, Maryland, United States

    Contact: Study coordinator (Corilynn Hughes) · corilynn.hughes@usoncology.com

  • Missouri Cancer Associates, Columbia, Missouri, United States

    Contact: Study coordinator (Crystal Johnson) · crystal.johnson@usoncology.com

  • Comprehensive Cancer Centers, Las Vegas, Nevada, United States

    Contact: Study coordinator (Lindsay Kondo) · lindsay.kondo@usoncology.com

  • Regional Cancer Care, Belleville, New Jersey, United States

    Contact: Study coordinator (Denise Johnstone) · denise.johnstone@regionalcancercare.org

  • NYU Langone Health, New York, New York, United States

    Contact: Study coordinator (Study Team) · ct.gov@nyulangone.org

  • Taylor Cancer Research Center, Maumee, Ohio, United States

    Contact: Study coordinator (Stephanie Ambrose) · sambrose@tcrcpt.org

  • Willamette Valley Cancer Institute, Eugene, Oregon, United States

    Contact: Study coordinator (Jeanne Schaffer) · jeanne.schaffer@usoncology.com

  • Thomas Jefferson University, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Study Team) · OncTrialNow@Jefferson.edu

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

    Contact: Study coordinator (Study Team) · SCRI.ResearchReferrals@scresearch.net

  • Texas Oncology - West Texas, Abilene, Texas, United States

    Contact: Study coordinator (Michole Logan) · michole.logan@usoncology.com

  • Texas Oncology - San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Shannon Syring) · shannon.syring@usoncology.com

  • Texas Oncology Gulf Coast, Webster, Texas, United States

    Contact: Study coordinator (Tara Gray) · tara.gray@usoncology.com

  • Blue Ridge Cancer Care, Blacksburg, Virginia, United States

    Contact: Study coordinator (Natasha Holt) · natasha.holt@usoncology.com

  • Virginia Cancer Specialists, Fairfax, Virginia, United States

    Contact: Study coordinator (Study Team) · VCSResearchReferrals@usoncology.com

  • Northwest Cancer Specialists, Vancouver, Washington, United States

    Contact: Study coordinator (Susan Papenfuse) · susan.papenfuse@usoncology.com

  • Calvary Mater Newcastle, Waratah, New South Wales, Australia

    Contact: Study coordinator (Prajwol Shrestha, MD)

  • Icon Cancer Centre - Chermside, Chermside, Queensland, Australia

    Contact: Study coordinator (Chun Gan, MD)
View source on ClinicalTrials.gov(opens in a new tab)